|Name||Position||Country||Term||Time in Office|
|M. Hallworth||Chair||UK||1st||2012 06 - 2014 12|
|C.R. Fantz||Member||US||1st||2012 06 - 2014 12|
|T. Higgins||Member||CA||1st||2012 06 - 2014 12|
|E. Kilpatrick||Member||UK||1st||2012 06 - 2014 12|
|S. Rana||Member||IN||1st||2012 06 - 2014 12|
|F. Vanstapel||Member||BE||1st||2012 06 - 2014 12|
|C. Ebert||Corp. Rep./Roche||DE||1st||2012 06 - 2014 12|
|S. Faye||Corp. Rep./Beckman Coulter||UK||1st||2012 06 - 2014 12|
|P. Gillery||SD Liaison||FR|
The TF-ICO has completed the remit in their original Terms of Reference but the topic of outcomes research remains of considerable importance to IFCC, and it will be incorporated into IFCC's ongoing agenda.
The results of the TF-ICO work were presented in Istanbul WorldLab in 2015, and at Euromedlab in Paris in June 2015.
Mike Hallworth's 2015 presentation is available for download here.
The TF-ICO prepared a special themed issue of the eJIFCC on the topic of how labs can improve clinical outcomes, including a series of articles written by Mario Plebani, Joanne Callen, Patrick Bossuyt, Bruce Jordan (Roche), Howard Morris and Danielle Freedman, plus a covering editorial by Mike Hallworth.
Dr. Mike Hallworth
Department of Clinical Biochemistry
Royal Shrewsbury Hospital
Mytton Oak Road
Shropshire SY3 8XQ, UK
Tel: +44 1743 261157
Fax: +44 1743 261159